Replies to post #71451 on Innovation Pharmaceuticals Inc (IPIX)

[BonelessCat]

Deserves a list:

B-ABSSSI Phase 2b results unblinded within about 4 weeks.
B-OM Phase 2/3a trial starting within a few weeks.
K Phase 1 dosing at 350 mg/m^2 still with no reported DLTs after a month.
K w/Cytarabine Phase 1b AML starting at University of Bologna in the next few weeks
P Phase 2/3a starting around the coming first quarter.

4 drugs in 5 clinical trials and all already funded. Not budgeted, funded. Link to ongoing and completed trials:

http://www.clinicaltrials.gov/ct2/results?term=cellceutix&Search=Search